Vivo Capital, a global healthcare investment firm, closed a new fund, at over $100m. Investors in The Vivo PANDA Fund include financial institutions, corporate entities, and family offices. The fund plans to invest the capital in innovative early-stage healthcare companies across pharmaceuticals, biotechnology, medical devices, and diagnostics. It will enable the firm to invest in […]